Further, two of the new directors will be appointed to Emageon’s Strategic Alternatives Committee, which is pursuing various options, including a sale of the Birmingham, Ala.-based company.
Following Emageon’s annual shareholder meeting in early July, two existing directors, Charles Jett and Douglas French, will resign from the board. Jett will continue as CEO at the board’s discretion. Augustus Oliver, a principal in Oliver Press Partners, said the changes unify the board and bring strong representation by significant shareholders.
More information is available at emageon.com.
Be the first to comment on this post using the section below.